Breaking News
FLASH SALE 0
🔎 FLASH SALE: 50% off InvestingPro | See what others miss, trade with confidence.
Claim Sale
Close

Adcock Ingram Holdings Limited (AIPJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7,390 -30    -0.40%
14/10 - Closed. Currency in ZAR
Type:  Equity
Market:  South Africa
ISIN:  ZAE000123436 
S/N:  AIP
  • Volume: 200,443
  • Bid/Ask: 7,125 / 7,420
  • Day's Range: 7,376 - 7,420
Adcock Ingram Holdings 7,390 -30 -0.40%

Adcock Ingram Holdings Limited Company Profile

 
Get an in-depth profile of Adcock Ingram Holdings Limited, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It also offers various products in the therapeutic areas, including hypertension, cholesterol, diabetes, depression, anxiety, insomnia, psychosis, epilepsy, dementia, pain, headache, inflammation, joint pain, gout, dipolar disorder, heartburn, acne, and bacterial and fungal infections. In addition, the company provides medicines for cardiovascular health, hyperlipidaemia, and metabolic syndrome; psychiatric and neurological diseases; dry skin, eczema, psoriasis, rosacea, and skin infection; and women’s health comprising bacterial vaginosis, menopause, osteoporosis, and urinary. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa. Adcock Ingram Holdings Limited is a subsidiary of The Bidvest Group Limited.

Contact Information

Address 1 New Road New Road & 7th Street
Midrand, 1682
South Africa
Phone 27 11 635 0000
Fax 27 86 553 0000

Top Executives

Name Age Since Title
Claudia Estelle Manning 59 2016 Independent Non-Executive Director
Debra Ransby 51 2019 Independent Non-Executive Director
Michael Sathekge - 2020 Independent Non-Executive Director
Basadifeela Letsoalo 62 2016 Executive Director of Transformation & Human Capital and Executive Director
Sibongile Gumbi 52 2019 Independent Non-Executive Director
Lulama Boyce 46 2017 Non-Executive Director
Mark John Steyn 55 2023 Non-Executive Director
Dorette Neethling 51 2015 CFO & Executive Director
Andrew Gideon Hall 63 2007 CEO & Executive Director
Busisiwe Abigail Mabuza 62 2022 Lead Independent Non-Executive Director
Nompumelelo Thembekile Madisa 46 2017 Non-Executive Chairperson
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AIPJ Comments

Write your thoughts about Adcock Ingram Holdings Limited
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email